Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. (Q51536238)

6 April 2018

title

Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. (English)

1 reference

6 April 2018

1 reference

placebo-controlled trial

1 reference

A Gough

1

1 reference

6 April 2018

M Clapperton

2

1 reference

6 April 2018

N Rolando

3

1 reference

6 April 2018

A V Foster

4

1 reference

6 April 2018

J Philpott-Howard

5

1 reference

6 April 2018

M E Edmonds

6

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 September 1997

1 reference

6 April 2018

published in

The Lancet

1 reference

6 April 2018

volume

350

1 reference

6 April 2018

issue

9081

1 reference

6 April 2018

page(s)

855-859

1 reference

6 April 2018

Diabetic foot infections. Pathophysiology and treatment.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Oxygen Metabolism and the Toxic Properties of Phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Chemotaxis of Polymorphonuclear Leukocytes from Patients with Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Endogenous haemopoietic growth factors in neutropenia and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Assessment and management of foot disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Assessment of the microcirculation provides additional information in critical limb ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Systemic antimicrobial treatment of foot infections in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

Leukocytes and the risk of ischemic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904495-4

7 January 2021

10.1016/S0140-6736(97)04495-4

Identifiers

DOI

1 reference

6 April 2018

release_o5tdgfiffrhzjnmy5pgoyyvuce

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o5tdgfiffrhzjnmy5pgoyyvuce

24 November 2022

mapped directly with Wikidata item

PubMed ID

9310604

1 reference

6 April 2018